COMMUNIQUÉS West-GlobeNewswire

Veritas Pharma Announces Loan to Marapharm and Cancellation of Stock Options
28/07/2018
VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that effective June 25, 2018, it [...]
Kalytera Therapeutics Announces Adjournment of 2018 Annual and Special Meeting
27/07/2018
SAN FRANCISCO and TEL AVIV, Israel, July 27, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company”, or “Kalytera”) (TSXV:KALY) (OTCQB:KALTF) announced today that the annual and special meeting of Kalytera [...]
CLS Holdings USA Appoints Frank Tarantino, CPA as Chief Financial Officer
27/07/2018
Adds Big Four Public Accounting and Public Company Experience LAS VEGAS, July 27, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences [...]
HEXO Supports Privatization of Retail Cannabis in Ontario
27/07/2018
GATINEAU, Quebec, July 27, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to hear reports that the Ontario government is considering the privatization of adult- [...]
HEXO appuie la privatisation des ventes au détail du cannabis en Ontario
27/07/2018
GATINEAU, Québec, 27 juill. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) est heureuse d’apprendre que le gouvernement de l’Ontario envisage la privatisation de la vente au [...]
INSYS Therapeutics Receives Complete Response Letter from FDA for Buprenorphine NDA
27/07/2018
PHOENIX, July 27, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY) announced that today it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the company [...]
Idera Pharmaceuticals Announces One-for-Eight Reverse Stock Split
27/07/2018
EXTON, Pa., July 27, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for [...]
CASMED to Report Second-Quarter 2018 Financial Results and Hold Conference Call on August 2
27/07/2018
BRANFORD, Conn., July 27, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED) , a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results [...]
The American Health Council Board of Nurses Welcomes Sarah Kavalauskas MSN, BSN, RN, PALS, ACLS, NRCME
27/07/2018
NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- The American Health Council is proud to appoint Sarah Kavalauskas MSN, BSN, RN, PALS, ACLS, NRCME to its Board of Nurses. Currently a Certified Nurse Practitioner at Health [...]
Cambrex to Announce Second Quarter 2018 Financial Results on August 2, 2018
27/07/2018
EAST RUTHERFORD, N.J., July 27, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
27/07/2018
IRVING, Texas, July 27, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced [...]
Lotus Facility Construction & Commissioning Update
27/07/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- ARMSTRONG FACILITY Construction of Lotus’ initial production [...]
MannKind and Tanner Pharma Group Enter into an ex-U.S. Distribution Agreement for Afrezza®
27/07/2018
WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such [...]
Coherus BioSciences Receives Positive CHMP Opinion for UDENYCA™ (Pegfilgrastim Biosimilar Candidate)
27/07/2018
REDWOOD CITY, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has [...]
MannKind Corporation to Hold 2018 Second Quarter Financial Results Conference Call on August 2, 2018
27/07/2018
WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will host a conference call to discuss the 2018 second quarter and year-to-date financial results and other corporate [...]
Aeroponics Can Change Cannabis Cultivation -- CFN Media
27/07/2018
SEATTLE, July 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
BlissCo Advances E-Commerce Program Ahead of Cannabis Legalization -- CFN Media
27/07/2018
SEATTLE, July 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
ContraFect Corporation Prices $10 Million Public Offering of Common Stock
27/07/2018
YONKERS, N.Y., July 27, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug- [...]
BioCryst to Announce Second Quarter 2018 Financial Results on August 7
27/07/2018
RESEARCH TRIANGLE PARK, N.C., July 27, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that its second quarter 2018 financial results will be reported on Tuesday, August 7, 2018. [...]

Pages